OnKure Therapeutics Statistics
Total Valuation
OKUR has a market cap or net worth of $57.29 million. The enterprise value is -$1.21 million.
Important Dates
The last earnings date was Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OKUR has 13.67 million shares outstanding. The number of shares has increased by 292.10% in one year.
| Current Share Class | 13.67M |
| Shares Outstanding | 13.67M |
| Shares Change (YoY) | +292.10% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 16.34% |
| Owned by Institutions (%) | 42.76% |
| Float | 5.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.02 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.28, with a Debt / Equity ratio of 0.01.
| Current Ratio | 10.28 |
| Quick Ratio | 9.97 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7,868.75 |
Financial Efficiency
Return on equity (ROE) is -74.39% and return on invested capital (ROIC) is -48.68%.
| Return on Equity (ROE) | -74.39% |
| Return on Assets (ROA) | -44.45% |
| Return on Invested Capital (ROIC) | -48.68% |
| Return on Capital Employed (ROCE) | -112.02% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 46 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.20% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -16.20% |
| 50-Day Moving Average | 2.97 |
| 200-Day Moving Average | 2.79 |
| Relative Strength Index (RSI) | 74.92 |
| Average Volume (20 Days) | 205,779 |
Short Selling Information
The latest short interest is 53,751, so 0.39% of the outstanding shares have been sold short.
| Short Interest | 53,751 |
| Short Previous Month | 33,385 |
| Short % of Shares Out | 0.39% |
| Short % of Float | 1.02% |
| Short Ratio (days to cover) | 0.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -62.95M |
| Pretax Income | -59.52M |
| Net Income | -59.52M |
| EBITDA | -62.50M |
| EBIT | -62.95M |
| Earnings Per Share (EPS) | -$4.40 |
Full Income Statement Balance Sheet
The company has $59.05 million in cash and $549,000 in debt, with a net cash position of $58.50 million or $4.28 per share.
| Cash & Cash Equivalents | 59.05M |
| Total Debt | 549,000 |
| Net Cash | 58.50M |
| Net Cash Per Share | $4.28 |
| Equity (Book Value) | 56.18M |
| Book Value Per Share | 4.11 |
| Working Capital | 54.92M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$51.83 million and capital expenditures -$46,000, giving a free cash flow of -$51.87 million.
| Operating Cash Flow | -51.83M |
| Capital Expenditures | -46,000 |
| Depreciation & Amortization | 447,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -51.87M |
| FCF Per Share | -$3.79 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OKUR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -292.10% |
| Shareholder Yield | -292.10% |
| Earnings Yield | -103.88% |
| FCF Yield | -90.54% |
Analyst Forecast
The average price target for OKUR is $27.00, which is 544.39% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.00 |
| Price Target Difference | 544.39% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |